We observed that NLRP3 inhibition with the orally active OLT1177 significantly reduced tumor growth of B16F10 melanoma; other studies also report the anti-tumor property of OLT1177 [21,25,29,104,105]. The gene discussed is NLRP3; the disease is neoplasm.